Selected research
Industry Research
Valpromide Industry Research Report 2026
Market perspective
The global Valpromide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Valpromide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Valpromide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Valpromide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Valpromide include Novartis Pharmaceuticals, Beijing Sail Biopharmaceutical Co., Ltd., Hunan Dino Pharmaceutical Co., Ltd., Hunan Hansen Pharmaceutical Co., Ltd., Hunan Xiangzhong Pharmaceutical Co., Ltd., China Resources Double-Crane Pharmaceutical Co., Ltd. and Shanxi Luliang Traditional Chinese Medicine Factory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Valpromide market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Valpromide Market by Company
Novartis Pharmaceuticals
Beijing Sail Biopharmaceutical Co., Ltd.
Hunan Dino Pharmaceutical Co., Ltd.
Hunan Hansen Pharmaceutical Co., Ltd.
Hunan Xiangzhong Pharmaceutical Co., Ltd.
China Resources Double-Crane Pharmaceutical Co., Ltd.
Shanxi Luliang Traditional Chinese Medicine Factory
Valpromide Segment by Type
Pill
Suppository
Capsule
Valpromide Segment by Application
Hospital
Pharmacy
Others
Valpromide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valpromide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valpromide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valpromide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Valpromide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Valpromide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Valpromide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pill
- Suppository
- Capsule
Applications
- Hospital
- Pharmacy
- Others
Companies covered
- Novartis Pharmaceuticals
- Beijing Sail Biopharmaceutical Co., Ltd.
- Hunan Dino Pharmaceutical Co., Ltd.
- Hunan Hansen Pharmaceutical Co., Ltd.
- Hunan Xiangzhong Pharmaceutical Co., Ltd.
- China Resources Double-Crane Pharmaceutical Co., Ltd.
- Shanxi Luliang Traditional Chinese Medicine Factory
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Valpromide Market Size (2021-2032)
- 2.2.2 Global Valpromide Sales (2021-2032)
- 2.2.3 Global Valpromide Market Average Price (2021-2032)
- 2.3 Valpromide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pill
- 2.3.3 Suppository
- 2.3.4 Capsule
- 2.4 Valpromide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Pharmacy
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Valpromide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Valpromide Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Valpromide Revenue of Manufacturers (2021-2026)
- 3.4 Global Valpromide Average Price by Manufacturers (2021-2026)
- 3.5 Global Valpromide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Valpromide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Valpromide, Product Type & Application
- 3.8 Global Manufacturers of Valpromide, Established Date
- 3.9 Global Valpromide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis Pharmaceuticals
- 4.1.1 Novartis Pharmaceuticals Company Information
- 4.1.2 Novartis Pharmaceuticals Business Overview
- 4.1.3 Novartis Pharmaceuticals Valpromide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Pharmaceuticals Valpromide Product Portfolio
- 4.1.5 Novartis Pharmaceuticals Recent Developments
- 4.2 Beijing Sail Biopharmaceutical Co., Ltd.
- 4.2.1 Beijing Sail Biopharmaceutical Co., Ltd. Company Information
- 4.2.2 Beijing Sail Biopharmaceutical Co., Ltd. Business Overview
- 4.2.3 Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Product Portfolio
- 4.2.5 Beijing Sail Biopharmaceutical Co., Ltd. Recent Developments
- 4.3 Hunan Dino Pharmaceutical Co., Ltd.
- 4.3.1 Hunan Dino Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Hunan Dino Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Hunan Dino Pharmaceutical Co., Ltd. Valpromide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hunan Dino Pharmaceutical Co., Ltd. Valpromide Product Portfolio
- 4.3.5 Hunan Dino Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Hunan Hansen Pharmaceutical Co., Ltd.
- 4.4.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Product Portfolio
- 4.4.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
- 4.5 Hunan Xiangzhong Pharmaceutical Co., Ltd.
- 4.5.1 Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Product Portfolio
- 4.5.5 Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments
- 4.6 China Resources Double-Crane Pharmaceutical Co., Ltd.
- 4.6.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Company Information
- 4.6.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Product Portfolio
- 4.6.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Shanxi Luliang Traditional Chinese Medicine Factory
- 4.7.1 Shanxi Luliang Traditional Chinese Medicine Factory Company Information
- 4.7.2 Shanxi Luliang Traditional Chinese Medicine Factory Business Overview
- 4.7.3 Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Product Portfolio
- 4.7.5 Shanxi Luliang Traditional Chinese Medicine Factory Recent Developments
5 Global Valpromide Market Scenario by Region
- 5.1 Global Valpromide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Valpromide Sales by Region: 2021-2032
- 5.2.1 Global Valpromide Sales by Region: 2021-2026
- 5.2.2 Global Valpromide Sales by Region: 2027-2032
- 5.3 Global Valpromide Revenue by Region: 2021-2032
- 5.3.1 Global Valpromide Revenue by Region: 2021-2026
- 5.3.2 Global Valpromide Revenue by Region: 2027-2032
- 5.4 North America Valpromide Market Facts & Figures by Country
- 5.4.1 North America Valpromide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Valpromide Sales by Country (2021-2032)
- 5.4.3 North America Valpromide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Valpromide Market Facts & Figures by Country
- 5.5.1 Europe Valpromide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Valpromide Sales by Country (2021-2032)
- 5.5.3 Europe Valpromide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Valpromide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Valpromide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Valpromide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Valpromide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Valpromide Market Facts & Figures by Country
- 5.7.1 South America Valpromide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Valpromide Sales by Country (2021-2032)
- 5.7.3 South America Valpromide Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Valpromide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Valpromide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Valpromide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Valpromide Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Valpromide Sales by Type (2021-2032)
- 6.1.1 Global Valpromide Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Valpromide Sales Market Share by Type (2021-2032)
- 6.2 Global Valpromide Revenue by Type (2021-2032)
- 6.2.1 Global Valpromide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Valpromide Revenue Market Share by Type (2021-2032)
- 6.3 Global Valpromide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Valpromide Sales by Application (2021-2032)
- 7.1.1 Global Valpromide Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Valpromide Sales Market Share by Application (2021-2032)
- 7.2 Global Valpromide Revenue by Application (2021-2032)
- 7.2.1 Global Valpromide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Valpromide Revenue Market Share by Application (2021-2032)
- 7.3 Global Valpromide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Valpromide Value Chain Analysis
- 8.1.1 Valpromide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Valpromide Production Mode & Process
- 8.2 Valpromide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Valpromide Distributors
- 8.2.3 Valpromide Customers
9 Global Valpromide Analyzing Market Dynamics
- 9.1 Valpromide Industry Trends
- 9.2 Valpromide Industry Drivers
- 9.3 Valpromide Industry Opportunities and Challenges
- 9.4 Valpromide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst